Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

New Drugs 09, Part 2

Hussar, Daniel A. PhD

doi: 10.1097/PSN.0b013e3181d0514a
ARTICLE: CONTINUING EDUCATION

In this article, you'll learn about six new drugs, including: • clevidipine, an I.V. antihypertensive for use when oral medication isn't feasible • romiplostim and eltrombopag olamine, new agents for chronic immune thrombocytopenic purpura • C1 inhibitor (human) for hereditary angioedema. Unless otherwise specified, the information in the following summaries applies to adults, not children. Consult the package insert for information about each drug's safety during pregnancy and breast-feeding. Also consult a pharmacist, the package insert, or a comprehensive drug reference for more details on precautions, drug interactions, and adverse reactions* for all these drugs.

Daniel A. Hussar, PhD, Remington Professor of Pharmacy, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Pa.

The author has disclosed that he has no significant relationship with or financial interest in any commercial companies that pertain to this educational activity.

Reprinted with permission from Nursing 2009. June 2009:33–39.

For more than 37 additional continuing education articles related to drug therapy topics, go to NursingCenter.com/CE.

Copyright © 2009 by American Society of Plastic Surgical Nurses